Approval · Notice of Compliance 16621 · 2015
AMOXICILLIN: Notice of Compliance 16621
Issued February 19, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16621
- Date
- February 19, 2015
- Company
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification number
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMOXICILLIN | 02237154 | Cancelled Pre Market |
Medicinal ingredients
- AMOXICILLIN 500 MG per CAP